KRAS Mutant Allele Fraction in Circulating Cell-Free DNA Correlates With Clinical Stage in Pancreatic Cancer Patients

Background: The research on circulating tumor DNA (ctDNA) in pancreatic cancer (PC) has emerged recently. Although the detection rate of the KRAS mutation in ctDNA was relatively consistent with that in tumor tissue, whether the KRAS mutant allele fraction (MAF) differed was still not reported. So f...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhe-Ying, Ding, Xiao-Qing, Zhu, Hui, Wang, Rui-Xian, Pan, Xiao-Rong, Tong, Jian-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896365/
https://www.ncbi.nlm.nih.gov/pubmed/31850201
http://dx.doi.org/10.3389/fonc.2019.01295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896365/
https://www.ncbi.nlm.nih.gov/pubmed/31850201
http://dx.doi.org/10.3389/fonc.2019.01295

Ejemplares similares